Cargando…

A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma

Carbohydrate antigen 19–9 (CA 19–9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Catherine, McLaren, Mairi, Mosse, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849326/
https://www.ncbi.nlm.nih.gov/pubmed/35186252
http://dx.doi.org/10.1093/jscr/rjac018
_version_ 1784652440427036672
author Hall, Catherine
McLaren, Mairi
Mosse, Charles
author_facet Hall, Catherine
McLaren, Mairi
Mosse, Charles
author_sort Hall, Catherine
collection PubMed
description Carbohydrate antigen 19–9 (CA 19–9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseudotumours. An 83-year-old woman presented with severe obstructive jaundice, weight loss and an extreme elevation of CA 19–9 level of 3295 kU/L. Magnetic resonance cholangiopancreatography (MRCP) revealed a pancreatic mass amputating the biliary tree. Liver function tests revealed a cholestatic pattern and severe hyperbilirubinaemia (289umol/L). IgG4 level was found to be high at 7.97 g/L. After treatment with high-dose corticosteroids, repeat MRCP 2 months later revealed disappearance of the pancreatic mass. There was also normalization of the bilirubin and a dramatic decrease of CA 19–9. This case reports the highest published benign elevation of Ca19.9 level in the setting of IgG4 disease. Differentiation between cholangiocarcinoma and IgG4-RD is important, as the treatment is vastly different.
format Online
Article
Text
id pubmed-8849326
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88493262022-02-17 A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma Hall, Catherine McLaren, Mairi Mosse, Charles J Surg Case Rep Case Report Carbohydrate antigen 19–9 (CA 19–9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseudotumours. An 83-year-old woman presented with severe obstructive jaundice, weight loss and an extreme elevation of CA 19–9 level of 3295 kU/L. Magnetic resonance cholangiopancreatography (MRCP) revealed a pancreatic mass amputating the biliary tree. Liver function tests revealed a cholestatic pattern and severe hyperbilirubinaemia (289umol/L). IgG4 level was found to be high at 7.97 g/L. After treatment with high-dose corticosteroids, repeat MRCP 2 months later revealed disappearance of the pancreatic mass. There was also normalization of the bilirubin and a dramatic decrease of CA 19–9. This case reports the highest published benign elevation of Ca19.9 level in the setting of IgG4 disease. Differentiation between cholangiocarcinoma and IgG4-RD is important, as the treatment is vastly different. Oxford University Press 2022-02-16 /pmc/articles/PMC8849326/ /pubmed/35186252 http://dx.doi.org/10.1093/jscr/rjac018 Text en Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author(s) 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Hall, Catherine
McLaren, Mairi
Mosse, Charles
A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma
title A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma
title_full A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma
title_fullStr A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma
title_full_unstemmed A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma
title_short A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma
title_sort pancreatic mass and extreme elevation of ca 19–9: a benign masquerade of cholangiocarcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849326/
https://www.ncbi.nlm.nih.gov/pubmed/35186252
http://dx.doi.org/10.1093/jscr/rjac018
work_keys_str_mv AT hallcatherine apancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma
AT mclarenmairi apancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma
AT mossecharles apancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma
AT hallcatherine pancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma
AT mclarenmairi pancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma
AT mossecharles pancreaticmassandextremeelevationofca199abenignmasqueradeofcholangiocarcinoma